Chronic obstructive pulmonary disease with short-acting inhaled pharmacotherapy increases the risk of prostate cancer: A two-stage database approach.

Hui-Wen LinLi-Fong LinHung-Chou ChenTsan-Hon LiouShih-Wei Huang

Published in: PloS one (2018)

Patients with COPD are at a higher risk of prostate cancer, particularly those using SAMAs or SABAs. This finding suggests that inflammation control may be an effective strategy for decreasing the risk of prostate cancer.

Keyphrases

prostate cancer
chronic obstructive pulmonary disease
radical prostatectomy
lung function
oxidative stress
cystic fibrosis
emergency department
adverse drug